Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 3
2012 2
2014 5
2015 1
2016 3
2017 1
2018 1
2019 4
2020 4
2021 3
2022 8
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Landscape of somatic alterations in large-scale solid tumors from an Asian population.
Wu L, Yao H, Chen H, Wang A, Guo K, Gou W, Yu Y, Li X, Yao M, Yuan S, Pang F, Hu J, Chen L, Liu W, Yao J, Zhang S, Dong X, Wang W, Hu J, Ling Q, Ding S, Wei Y, Li Q, Cao W, Wang S, Di Y, Feng F, Zhao G, Zhang J, Huang L, Xu J, Yan W, Tong Z, Jiang D, Ji T, Li Q, Xu L, He H, Shang L, Liu J, Wang K, Wu D, Shen J, Liu Y, Zhang T, Liang C, Wang Y, Shang Y, Guo J, Liang G, Xu S, Liu J, Wang K, Wang M. Wu L, et al. Among authors: shang y. Nat Commun. 2022 Jul 23;13(1):4264. doi: 10.1038/s41467-022-31780-9. Nat Commun. 2022. PMID: 35871175 Free PMC article.
erm(T)-Mediated Macrolide-Lincosamide Resistance in Streptococcus suis.
Yu R, Xu Y, Schwarz S, Shang Y, Yuan X, Zhang Y, Li D, Du XD. Yu R, et al. Among authors: shang y. Microbiol Spectr. 2022 Feb 23;10(1):e0165721. doi: 10.1128/spectrum.01657-21. Epub 2022 Jan 12. Microbiol Spectr. 2022. PMID: 35019703 Free PMC article.
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study.
Zhang L, Wang L, Wang J, Chen J, Meng Z, Liu Z, Jiang X, Wang X, Huang C, Chen P, Liang Y, Jiang R, Wang J, Zhong D, Shang Y, Zhang Y, Zhang C, Huang D. Zhang L, et al. Among authors: shang y. Mol Cancer. 2023 Aug 5;22(1):124. doi: 10.1186/s12943-023-01823-w. Mol Cancer. 2023. PMID: 37543587 Free PMC article. Clinical Trial.
40 results